EWPI (Emerging World Pharma) EV-to-EBIT: (As of Jul. 12, 2026)


What is Emerging World Pharma EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Emerging World Pharma's Enterprise Value is $0.00 Mil. Emerging World Pharma does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Emerging World Pharma's EV-to-EBIT at this moment.

The historical rank and industry rank for Emerging World Pharma's EV-to-EBIT or its related term are showing as below:

EWPI's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.865
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Emerging World Pharma's Enterprise Value for the quarter that ended in . 20 was $0.00 Mil. Emerging World Pharma does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Emerging World Pharma's Earnings Yield (Joel Greenblatt) % at this moment.

Emerging World Pharma  (OTCPK:EWPI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Emerging World Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Emerging World Pharma EV-to-EBIT Related Terms

Emerging World Pharma EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma EV-to-EBIT Chart

Emerging World Pharma Annual Data
Trend
EV-to-EBIT

Emerging World Pharma Quarterly Data
EV-to-EBIT

EWPI vs ENZB, AOXG: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Emerging World Pharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emerging World Pharma EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emerging World Pharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Emerging World Pharma's EV-to-EBIT falls into.


Emerging World Pharma EV-to-EBIT Calculation

Emerging World Pharma's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.